UHC Coalition: Realizing the Promise of Universal Health Coverage
When we marked UHC Day at this time last year, the world had just adopted the Sustainable Development Goals, including Universal Health Coverage as a target. This was worth celebrating.
An experience from Belarus on how allocative efficiency analysis changed HIV budgets
Belarus’ HIV response is faced with the need to provide treatment to a larger number of people living with HIV than ever before and to simultaneously continue scaling up prevention. How to do this in a context of limited resources, poses a major challenge for any planner. Most recent HIV estimates from Belarus illustrate the rapidly growing challenge. UNAIDS estimated that the number of PLHIV in Belarus increased from 5,600 in the year 2000 to 35,000 in 2015. New HIV infections increased from 1,700 per year in 2000 to 2,600 in 2010 and then doubled again to reach 5,300 in 2015.
Sergio Carmona and Tendesayi Kufa-Chakezha are guest blog contributers from South African National Department of Health: National Health Laboratory Services and South African National Department of Health: National Institute of Communicable Diseases, respectively.
South Africa has the largest HIV treatment program in the world with over 3 million people currently on antiretrovirals. Every year, millions of VL and CD4 count tests are carried out to check treatment eligibility for new HIV cases (CD4 count) and treatment success in those on antiretroviral therapy (ART). A VL test monitors viral suppression, the goal of ART given to a HIV-infected person. The CD4 count checks whether the patient suffers from immune deficiency due to low CD4 counts and tracks recovery of the immune system during ART. In 2014, close to half of all VL tests carried out in lower-middle income countries were done in South Africa. In addition, large numbers of CD4 cell counts have been done routinely to predict patients’ risks for opportunistic infections and provide preventive therapy where indicated. While VL and CD4 testing are essential to monitor individual ART patients, the data is also useful in tracking the impact and performance of the ART program as a whole.
Kofi Annan, the former Secretary-General of the United Nations, observed that knowledge is power and information is liberating. Indeed, the collection, analysis and dissemination of data and information should not be seen only as an instrument of scientific inquiry but more importantly, as a critical tool for guiding the formulation and implementation of policies to address complex problems in society.
The recent Durban 2016 International AIDS Conference celebrates the success of AIDS treatment in reducing illness and death. The pall of despair and wasting death that hung over the Durban 2000 International AIDS Conference has truly been lifted. In KwaZulu-Natal, where the conference was held, AIDS treatment has increased community life expectancy by a full 11 years, reversing decades of decline -- life expectancy in KwaZulu-Natal is higher today than before the HIV epidemic. This is indubitably one of the great successes of global health.
Dear Colleagues and Friends,
I wanted to take this opportunity to wish you a Happy New Year, and reflect on several notable events from 2015 - a year of remarkable progress in global health, and remarkable expansion for the World Bank Group's health, nutrition and population portfolio, which grew to more than $10 billion.
The World Bank Group’s new Gender Equality Strategy for 2016-2023, launched last week, addresses gender inclusion not just as a goal in and of itself, but one critical to development effectiveness.
World AIDS Day 2015 marks an unheralded but profound increase in our response to HIV and other major infectious diseases. In the last year, HIV diagnostics and medicines have made a real step change, as better and cheaper viral load tests and lower-dose, less toxic, more effective and cheaper drugs come to market. Drug costs are at their lowest ever, with generic first-line regimens costing $95-158 per patient per year – a 60-70% reduction from 2007-2014.
Penicillin was discovered almost 90 years ago and heralded the beginning of a revolutionary era in medicine. As the first antibiotic drug in existence, it was used to treat what had previously been severe and life-threatening illnesses, such as meningitis, pneumonia, and syphilis.